Jin Kim Selected Research

Jin Kim Research Topics

Disease

85	Neoplasms (Cancer) 01/2022 - 10/2002
24	Fibrosis (Cirrhosis) 02/2022 - 07/2002
17	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 09/2002
16	Rectal Neoplasms (Rectal Cancer) 03/2022 - 11/2012
12	Stomach Neoplasms (Stomach Cancer) 03/2018 - 10/2006
11	Squamous Cell Carcinoma of Head and Neck 01/2019 - 06/2006
11	Inflammation (Inflammations) 02/2018 - 02/2003
10	Carcinoma (Carcinomatosis) 01/2020 - 01/2007
9	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 03/2002
8	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2002
8	Carcinogenesis 01/2021 - 07/2003
7	Facial Paralysis (Facial Palsy) 11/2016 - 08/2009
7	Reperfusion Injury 10/2007 - 04/2001
6	Hepatocellular Carcinoma (Hepatoma) 03/2015 - 12/2002
6	Ischemia 06/2013 - 12/2002
5	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 01/2019
5	Wounds and Injuries (Trauma) 01/2020 - 06/2010
5	Hypokalemia 01/2019 - 06/2002
5	Mouth Neoplasms (Oral Cancer) 05/2017 - 10/2005
4	Infections 07/2021 - 05/2003
4	Anastomotic Leak 02/2019 - 01/2011
4	Adenocarcinoma 05/2015 - 12/2002
4	Necrosis 08/2014 - 12/2002
4	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2008 - 06/2002
4	Acidosis 01/2008 - 06/2002
3	Margins of Excision 09/2021 - 10/2006
3	Hyperplasia 01/2020 - 09/2012
3	Bell Palsy (Bell's Palsy) 11/2019 - 01/2016
3	Cicatrix (Scar) 08/2018 - 02/2002
3	Hypertension (High Blood Pressure) 12/2017 - 01/2006
3	Herpes Zoster Oticus (Geniculate Neuralgia) 11/2016 - 03/2008
3	Facial Asymmetry 01/2015 - 11/2010
3	Paralysis (Palsy) 02/2013 - 01/2010
3	Body Weight (Weight, Body) 01/2011 - 02/2003

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
14	Messenger RNA (mRNA)IBA 01/2021 - 11/2001
11	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2011 - 12/2002
10	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2022 - 07/2002
8	OsteopontinIBA 09/2016 - 07/2002
7	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
7	Biomarkers (Surrogate Marker)IBA 05/2019 - 09/2006
7	Biological ProductsIBA 01/2016 - 10/2003
6	CollagenIBA 04/2022 - 04/2004
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2008
6	CytokinesIBA 08/2020 - 01/2005
5	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2009
5	SodiumIBA 01/2018 - 11/2001
5	Cadherins (E-Cadherin)IBA 03/2016 - 05/2007
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2014 - 09/2004
5	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2005 - 02/2003
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2022 - 09/2003
4	AcidsIBA 01/2021 - 10/2007
4	Therapeutic UsesIBA 04/2020 - 02/2007
4	EnzymesIBA 01/2020 - 11/2005
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 02/2009
4	Type A Botulinum Toxins (Botox)FDA Link 09/2016 - 02/2013
4	Botulinum Toxins (Botulinum Toxin)IBA 09/2016 - 02/2013
4	SteroidsIBA 10/2014 - 09/2009
4	AmmoniaIBA 10/2011 - 10/2006
4	beta CateninIBA 03/2008 - 12/2006
4	CreatinineIBA 01/2005 - 10/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2009
3	Tacrolimus (Prograf)FDA LinkGeneric 11/2021 - 12/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 04/2013
3	AntioxidantsIBA 08/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 08/2020 - 01/2018
3	CateninsIBA 04/2020 - 03/2016
3	AntibodiesIBA 11/2019 - 04/2002
3	InflammasomesIBA 01/2019 - 09/2014
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2007
3	pheophorbide aIBA 05/2017 - 01/2015
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2017 - 01/2015
3	LigandsIBA 09/2016 - 02/2002
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2016 - 03/2011
3	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 02/2003
3	LipidsIBA 09/2014 - 01/2004
3	Insulin (Novolin)FDA Link 01/2013 - 02/2003
3	Complementary DNA (cDNA)IBA 02/2012 - 10/2009
3	Glycoproteins (Glycoprotein)IBA 10/2011 - 09/2006
3	Mitogen-Activated Protein KinasesIBA 07/2009 - 01/2003
3	Angiotensin IIIBA 08/2005 - 02/2003

Therapy/Procedure

17	Therapeutics 01/2022 - 12/2002
7	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 10/2006
5	Decompression 01/2021 - 08/2009
5	Ileostomy 08/2019 - 01/2013
5	Operative Time 08/2019 - 06/2012
5	Chemoradiotherapy 04/2019 - 11/2012
5	Aftercare (After-Treatment) 01/2019 - 05/2009
4	Drug Therapy (Chemotherapy) 07/2021 - 09/2012
4	Colectomy 09/2020 - 10/2011
4	Injections 09/2016 - 03/2006
3	Minimally Invasive Surgical Procedures 07/2022 - 01/2011
3	Neoadjuvant Therapy 09/2021 - 04/2019
3	Length of Stay 08/2019 - 09/2015
3	Photochemotherapy (Photodynamic Therapy) 05/2017 - 01/2015
3	Radiotherapy 01/2016 - 12/2009
3	Gastrectomy 09/2015 - 10/2006
3	Conservative Treatment 10/2013 - 04/2010